2,3,4,6-TETRA-O-PIVALOYL-ALPHA-D-GLUCOPYRANOSYL URUBUGA RWA OYA.81058-27-7
| Izina | 2,3,4,6-TETRA-O-PIVALOYL-ALPHA-D-GLUCOPYRANOSYL UMUGORE | ||
| URUBANZA OYA. | 81058-27-7 | ||
| Inzira ya molekulari | C26H43BrO9 | Uburemere bwa molekile | 579.53 |
| MDL No. | MFCD08275217 | EINECS | 686-241-8 |
| Depite | 147-148 ° C. | BP | 530.5 ± 50.0 ° C (Biteganijwe) |
| Ubucucike | 1.22 ± 0.1 g / cm3 (Biteganijwe) | Ironderero | NA |
| FP | NA | Imiterere y'ububiko | Ikirere cyinjiza, 2-8 ° C. |
| Kugaragara | Umweru Kuri Off-White ikomeye | ||
| Isuku | 98% | ||
| Gusaba | Canagliflozin abahuza, irashobora gukoreshwa mugutegura canagliflozin.Canagliflozin niwo muti wa mbere wemewe na FDA SGLT2 inhibitor, ushobora kugabanya isukari mu maraso mu kumena glucose no kuyisohora mu mpyiko, kandi ikoreshwa mu kuvura diyabete yo mu bwoko bwa 2 ku bantu bakuru | ||
| Gutanga Ubushobozi | 2,3,4,6-TETRA-O-PIVALOYL-ALPHA-D-GLUCOPYRANOSYL URUGENDO RWA BROMIDE URUBANZA NO.81058-27-7 nigicuruzwa cyacu gikora buri gihe, waba ukeneye icyitegererezo gito cyangwa imizigo minini irenga tonnage, isosiyete yacu irashobora kubitanga muburyo busanzwe | ||
| Niba ushimishijwe na 2,3,4,6-TETRA-O-PIVALOYL-ALPHA-D-GLUCOPYRANOSYL URUGENDO RWA BROMIDE URUBANZA NO.81058-27-7, umva utubwire nyamuneka, kandi tuzaguha ibicuruzwa byiza, igiciro cyiza na serivisi nziza, dutegereje ubufatanye. | |
| E-imeri | |
| Terefone No. | +86 139 6251 3054 +86 136 2174 3828 |
Ibicuruzwa byashyizwe ku rutonde nisosiyete birimo patenti, bigenewe ubushakashatsi niterambere gusa ntabwo bigurishwa;ibicuruzwa bigenzurwa bizagurishwa hubahirijwe cyane amategeko y’Ubushinwa n’amategeko y’igihugu aho bigurwa, kandi ibicuruzwa byose ntibikwiriye gukoreshwa n'abantu.Nibigurishwa, bizaba bigize igihugu kibangamiye ipatanti, ingaruka zose zijyanye nazo zizagurwa nuwaguze.
Andika ubutumwa bwawe hano hanyuma utwohereze
![2- (4-Fluorophenyl) -5 - [(5-iodo-2-methylphenyl) methyl] thiophene CAS OYA.898566-17-1](http://cdn.globalso.com/shlzpharma/898566-17-1.jpeg)
